For Financial Professionals in the US

JFNIX Global Life Sciences Fund

The fund/portfolio seeks to harness the rapid innovation in health care to generate returns by investing in companies addressing unmet medical needs or those that seek to make the health care system more efficient.

NAV
$65.37
As of 12/08/2023

1-Day Change
-$0.18 (-0.27%)
 As of 12/08/2023

YTD Return
1.48%
As of 12/08/2023

Morningstar Rating

As of 11/30/2023

Overview

Quarterly Update

Watch the investment team recap this quarter.

(Note: Filmed in October 2023).

ABOUT THIS FUND

The fund seeks to harness the rapid innovation in health care to generate returns by investing in companies addressing unmet medical needs or those that seek to make the health care system more efficient.

WHY INVEST IN THIS FUND

Health Care Expertise: Our domain experts have 95+ years of combined experience investing in the complex and dynamic health care sector. Our team of specialists, which include multiple Ph.D.’s, seek to understand both the science and the business of prospective investments.

Balanced Approach: We diversify the portfolio across market capitalizations, geographies and the primary sub-sectors of health care, including investments in biotechnology, health care services, medical devices and pharmaceuticals.

Integrated Risk Management Process: Security-level “Value at Risk” framework focuses attention on downside risks by limiting the position size of higher-risk stocks.

PORTFOLIO MANAGEMENT

Andy Acker, CFA

Andy Acker, CFA

Portfolio Manager

Industry since 1996. Joined Firm in 1999.

Daniel Lyons, Ph.D., CFA

Daniel Lyons, Ph.D., CFA

Portfolio Manager | Research Analyst

Industry since 2000. Joined Firm in 2000.

Performance

RETURNS (%) (As of 09/30/2023)
Global Life Sciences Fund - I Shares MSCI World Health Care IndexSM S&P 500® Index
 
3M YTD 1YR 3YR 5YR 10YR Since Inception
(12/31/1998)
Global Life Sciences Fund - I Shares -4.09 -0.89 13.06 5.56 7.77 11.72 11.09
MSCI World Health Care IndexSM -2.75 -1.99 10.88 5.86 7.07 9.32 6.54
S&P 500® Index -3.27 13.06 21.61 10.15 9.91 11.91 7.16
Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.
Performance for Class I Shares that includes periods prior to 7/6/09 reflects the performance of one or more share classes of the Fund or a predecessor fund, adjusted, where applicable and permitted, for differing fees and expenses. See the Fund’s prospectus for further details.

Returns include reinvestment of dividends and capital gains. Returns greater than one year are annualized.

RETURNS (%) (As of 11/30/2023)
Global Life Sciences Fund - I Shares MSCI World Health Care IndexSM S&P 500® Index
 
3M YTD 1YR 3YR 5YR 10YR Since Inception
(12/31/1998)
Global Life Sciences Fund - I Shares -2.89 -0.02 -0.90 2.95 8.98 11.13 11.05
MSCI World Health Care IndexSM -1.91 -0.63 -1.81 5.09 7.68 8.65 6.56
S&P 500® Index 1.74 20.79 13.83 9.76 12.51 11.81 7.39
Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.
Performance for Class I Shares that includes periods prior to 7/6/09 reflects the performance of one or more share classes of the Fund or a predecessor fund, adjusted, where applicable and permitted, for differing fees and expenses. See the Fund’s prospectus for further details.

Returns include reinvestment of dividends and capital gains. Returns greater than one year are annualized.

Calendar Year Returns (%)
Global Life Sciences Fund - I Shares MSCI World Health Care IndexSM
2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Global Life Sciences Fund - I Shares -2.64 6.86 25.60 29.28 4.41 22.66 -12.26 8.42 34.92 55.96
MSCI World Health Care IndexSM -5.41 19.80 13.51 23.24 2.51 19.79 -6.81 6.59 18.09 36.26

MORNINGSTAR PERCENTILE

(As Of 09/30/2023)
1 YR 3 YR 5 YR 10 YR SINCE INCEPTION
Percentile Ranking 7 22 8 9 13
Health | Rank/Count 18/174 30/157 14/137 9/125 5/57
(As Of 11/30/2023)
1 YR 3 YR 5 YR 10 YR SINCE INCEPTION
Percentile Ranking 10 27 5 9 13
Health | Rank / Count 22/176 42/158 12/138 10/127 5/57

RETURNS-BASED STATISTICS (As of 10/31/2023 Class I Shares)

RISK / REWARD
VS. MSCI World Health Care NR Index		 3YR 5YR
Information Ratio -0.31 0.07
Alpha -1.72 0.58
Tracking Error 6.25 6.51
Beta 0.97 1.02
R-squared (%) 84.19 84.84
UP/DOWN MARKET CAPTURE (%)
VS. MSCI World Health Care NR Index		 3YR 5YR
Up Capture Ratio 83.79 100.91
Down Capture Ratio 94.12 98.72
STANDARD DEVIATION 3YR 5YR
Global Life Sciences Fund 15.53 16.69
MSCI World Health Care NR Index 14.65 15.05
SHARPE RATIO 3YR 5YR
Global Life Sciences Fund 0.13 0.38
MSCI World Health Care NR Index 0.28 0.38
ANNUAL FEES & EXPENSES (As of the most recent prospectus)
CLASS I SHARES
Management Fees 0.64%
Other Expenses 0.12%
Total Gross Expenses 0.76%
Total Net Expenses 0.76%

Portfolio

Index represents the MSCI World Health Care Index.

Top Holdings (As of 10/31/2023)
% of Fund
UnitedHealth Group Inc 7.50
Eli Lilly & Co 5.40
Novo Nordisk A/S 4.37
AstraZeneca PLC 4.12
Merck & Co Inc 3.18
Sanofi SA 2.80
AbbVie Inc 2.68
Abbott Laboratories 2.65
Vertex Pharmaceuticals Inc 2.59
Novartis AG (ADR) 2.50
Total 37.79
View full holdings
Portfolio Characteristics (As of 10/31/2023)
  FUND INDEX
Number of Holdings
Equity Issues		 119 138
Market Capitalization
Weighted Average		 $145.64B $181.65B
Portfolio Turnover Rate
(1-year trailing)		 35.04% -
Price/Earnings Ratio
(1-year forward)		 17.97 16.12
Price/Book Ratio
 4.31 3.92
Earnings Growth Rate
(1-year forward)		 17.37% 13.22%
Sector Allocation % OF FUND % of Index % OF FUND % of Index (As of 10/31/2023)
Regional Allocation % OF FUND % of Index % OF FUND % of Index (As of 10/31/2023)
Market Capitalization Range of Equity Holdings % OF FUND % of Index % OF FUND % of Index (As of 10/31/2023)
Developed vs Emerging Markets % OF FUND % of Index % OF FUND % of Index (As of 10/31/2023)

Documents

Related Insights

Our intellectual capital is readily available and central to our Knowledge Shared approach"
Related Insights
Healthcare stocks: Positioned for a smoother ride in 2024?
Nov 29, 2023
Timely & Topical

Healthcare stocks: Positioned for a smoother ride in 2024?

Andy Acker and Dan Lyons share their outlook, saying a rapid pace of innovation and attractive valuations could propel the sector higher.

8 min read

Medical devices, tools, and insurers make the case for a rebound
Nov 9, 2023
Timely & Topical

Medical devices, tools, and insurers make the case for a rebound

These healthcare subsectors offer an attractive combination of long-term growth drivers at below-average valuations.

7 min read

Four questions: Why invest in healthcare now?
Oct 26, 2023
Timely & Topical

Four questions: Why invest in healthcare now?

Hear how advances in drug development, patient outcomes, and other trends are impacting the investment outlook for healthcare.

3 min read